USD
Increase targetBefore 14.92%Target 16%
Cash allocation. No separate rationale was supplied.
Strategy decision
Loading the recorded decision…
Targets, reasoning, and execution evidence will appear here.
Strategy decision
Targets, reasoning, and execution evidence will appear here.
Strategy decision
Sep 18, 2026, 8:19 AM EDT
Using this strategy in your portfolio? Open the Builder to review its source targets. Review your saved portfolio →
The decision
The ledger favors 84.00% in 12 diversified equities and 16.00% cash: valuation anchors mostly sit at 10.64-18.21 P/E, while selected price evidence is positive or deliberately sized as a recovery setup. I am selling the 36x earnings enthusiasm and trimming momentum concentration; cash remains dry powder for arithmetic that improves rather than stories that merely accelerate.
Targets & reasoning
Before is the portfolio weight captured at decision time. Target is the requested allocation—not confirmation of a completed trade. These are simulated strategy weights, not personalized allocations.
Cash allocation. No separate rationale was supplied.
I expect HCA to be a core compounder because its 15.66 P/E is restrained while its 20-session return is a constructive 5.40%; that combination is better arithmetic than an expensive breakout. I’m wrong if price momentum fails or the currently moderate earnings multiple loses its discount.
Recorded Sep 18, 2026, 8:19 AM EDT · Conviction: high · Horizon: quarters
I expect ACN to compound acceptably because its 15.20 P/E, 3.43% trailing yield, and 3.89% 20-session return make the spreadsheet unusually cooperative. I’m wrong if price strength reverses or earnings valuation ceases to be attractive against the other available arithmetic.
Recorded Sep 18, 2026, 8:19 AM EDT · Conviction: high · Horizon: quarters
I expect PGR to anchor the portfolio with a 10.64 P/E and 6.43% trailing yield despite nearly flat 20-session performance; cheap, quiet arithmetic deserves capital. I’m wrong if the modest price weakness deepens or the reported fair-to-slightly-elevated valuation assessment proves more relevant than the earnings multiple.
Recorded Sep 18, 2026, 8:19 AM EDT · Conviction: high · Horizon: quarters
I expect CB to provide a steadier financial sleeve because its 14.54 P/E is among the lower figures and its 20-session return is marginally positive rather than collapsing. I’m wrong if that price stability breaks down or the valuation discount no longer distinguishes it from peers.
Recorded Sep 18, 2026, 8:19 AM EDT · Conviction: medium · Horizon: quarters
I expect COP to add reasonable energy participation because a 16.75 P/E and 2.52% trailing yield accompany a positive 2.00% 20-session return. I’m wrong if momentum turns negative and the earnings multiple expands without corresponding support in the supplied arithmetic.
Recorded Sep 18, 2026, 8:19 AM EDT · Conviction: medium · Horizon: months
I expect INTU’s 12.44 P/E and 1.53% trailing yield to create a recovery opportunity after its 13.61% 20-session decline, with the position sized for unresolved tape risk. I’m wrong if selling persists and the unusually low valuation does not stabilize demand.
Recorded Sep 18, 2026, 8:19 AM EDT · Conviction: medium · Horizon: months
I expect MO’s 12.70 P/E, 6.15% trailing yield, and 5.56% 20-session gain to supply inexpensive total-return ballast. I’m wrong if the documented long-term risk from declining cigarette shipments outweighs pricing power and the positive price evidence fails.
Recorded Sep 18, 2026, 8:19 AM EDT · Conviction: medium · Horizon: quarters
I expect MPC to retain energy upside because its 15.11 P/E is still reasonable despite a strong 16.97% 20-session return; the numbers permit participation without a maximum weight. I’m wrong if the momentum fades and the valuation becomes less compelling than the other energy arithmetic.
Recorded Sep 18, 2026, 8:19 AM EDT · Conviction: medium · Horizon: months
I expect ADBE’s 14.89 P/E to provide recovery arithmetic after its 7.27% 20-session decline; this is a measured allocation because the price column is still red. I’m wrong if the decline persists and the low multiple fails to attract renewed demand.
Recorded Sep 18, 2026, 8:19 AM EDT · Conviction: medium · Horizon: months
I expect CRM’s 17.84% 20-session strength to support further participation, but the 22.36 P/E keeps this below core weight; momentum earns a seat, not a blank check. I’m wrong if the sharp price advance reverses or the multiple rises beyond what this disciplined allocation can justify.
Recorded Sep 18, 2026, 8:19 AM EDT · Conviction: medium · Horizon: months
I expect QCOM’s 13.52 P/E and 16.55% 20-session return to support a contained upside allocation, but margin-pressure evidence prevents core sizing. I’m wrong if QCT margins remain compressed as described, or if the current momentum reverses before the low multiple can do useful work.
Recorded Sep 18, 2026, 8:19 AM EDT · Conviction: medium · Horizon: months
I expect WFC’s 12.67 P/E, 2.13% trailing yield, and positive 1.11% 20-session return to provide inexpensive bank exposure without demanding a heroic narrative. I’m wrong if the modest positive tape turns persistently negative or the valuation advantage disappears.
Recorded Sep 18, 2026, 8:19 AM EDT · Conviction: medium · Horizon: quarters
Exit DE because its 36.43 P/E is the wrong arithmetic after an 18.08% 20-session advance. The portfolio can retain industrial exposure only when enthusiasm is not already charging premium rent.
Recorded Sep 18, 2026, 8:19 AM EDT · Conviction: high · Horizon: weeks
Exit TMO because its 37.28 P/E is too expensive for this GARP ledger despite a positive 7.30% 20-session return. The current evidence does not justify paying the portfolio’s highest valuation for momentum.
Recorded Sep 18, 2026, 8:19 AM EDT · Conviction: high · Horizon: weeks
Exit VLO to reduce refinery concentration after a 19.14% 20-session gain; the supplied commentary also notes elevated valuation metrics and margin-normalization risk. MPC and COP retain cheaper, more measured energy exposure.
Recorded Sep 18, 2026, 8:19 AM EDT · Conviction: high · Horizon: weeks
Portfolio checks
The complete proposal passed the versioned universe, cash, concentration, and posture constraints without platform modification.
These checks cover portfolio constraints. A separate portfolio-level investment-risk assessment was not supplied in this field. Review the holding explanations for recorded thesis and exit conditions.
Ongoing review
Monitor owned and favored symbols against the current mandate and rebalance through platform risk controls. Monitor for mandate drift. Rebalance through platform risk controls when targets shift materially.
This is the platform's monitoring description for the strategy, not a forecast from this decision.
Decision ≠ execution
This view shows one representative order and fill, not every leg of a rebalance. A recorded fill below does not confirm that all target weights were reached. Open the strategy portfolio to inspect current holdings.
Evidence behind the explanation
The explanations above preserve the reasoning recorded with this decision. The record details below show processing and execution history. They do not provide source documents for the financial claims in the explanations.
This checks record linkage, not investment quality or completion of every trade.
These identify processing inputs and validation steps. They are not linked research sources.
Growth At Reasonable Price cycle started by scheduled.
Growth At Reasonable Price produced a canonical target-weight decision.
Created sell proposal for ACN-USD.
Risk engine approved proposal 01M2T7C3DM5XXZ7GTQ0X0HNPFM.
Queued sell order for ACN-USD for MOO execution.
Growth At Reasonable Price cycle completed with status pending_fill.
Growth At Reasonable Price valuation snapshot recorded for agent_cycle_run 01M2T79FCRQ2YS4KJZ76GEGY1E.
Assumed MOO sell fill for ACN-USD at the verified session open.
Simulated sell fill for ACN-USD at the verified MOO session open.
Recorded balanced ledger entries for assumed MOO fill.